CellSource Co Ltd
TSE:4880
CellSource Co Ltd
Cash from Operating Activities
CellSource Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CellSource Co Ltd
TSE:4880
|
Cash from Operating Activities
¥846.7m
|
CAGR 3-Years
37%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Carna Biosciences Inc
TSE:4572
|
Cash from Operating Activities
-¥1.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-21%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cash from Operating Activities
¥6.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Medinet Co Ltd
TSE:2370
|
Cash from Operating Activities
-¥1.3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-9%
|
|
Linical Co Ltd
TSE:2183
|
Cash from Operating Activities
¥1.8B
|
CAGR 3-Years
143%
|
CAGR 5-Years
29%
|
CAGR 10-Years
25%
|
|
WDB coco Co Ltd
TSE:7079
|
Cash from Operating Activities
¥517.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is CellSource Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
846.7m
JPY
Based on the financial report for Oct 31, 2023, CellSource Co Ltd's Cash from Operating Activities amounts to 846.7m JPY.
What is CellSource Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
32%
Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for CellSource Co Ltd have been 37% over the past three years , 32% over the past five years .